Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis

NCT06872138 is registered in ClinicalTrials.gov with Theodor Bilharz Research Institute as lead sponsor.

NCT NCT06872138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06872138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis
Lead sponsor
Theodor Bilharz Research Institute
Phase
Observational
Overall status
Completed
Start date
November 1, 2024
Completion date
March 30, 2025
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarker, lupus, nephritis, s100a8, serum, urine